title: Suppression of amyloidogenesis in a mouse model by corticosteroid intervention.
abstract: Steroid treatment of amyloidosis was studied previously in human and murine models of reactive amyloidosis but with limited success and with conflicting results. To determine whether steroids may inhibit amyloidogenesis, and to study factors that may play a role in this effect, the authors induced amyloidosis in Swiss male mice, using the enhanced protocol with a single intravenous injection of amyloid-enhancing factor (AEF) and 3 successive daily subcutaneous AgNO(3) injections. Suppression of amyloid formation by various commonly used steroid preparations was evaluated from the amount of splenic amyloid, using the crush-and-smear technique. All steroid preparations examined were found to suppress amyloidogenesis but with differences between them in the degree and duration of inhibition. In general, hydrocortisone and dexamethasone had the highest suppressive effect, whereas methylprednisolone displayed lower activity for shorter duration. Single-dose experiments revealed that steroid effect is limited to the onset of amyloidogenesis. These experiments show that corticosteroids may significantly suppress amyloidogenesis but only briefly and, therefore, discourage a long-term and late use of steroid supplement in different anti-amyloid treatment protocols.
authors.affiliation: Heller Institute of Medical Research, Sheba Medical Center, Tel-Hashomer, Isreal. shmuels@sheba.health.gov.il
authors.forename: Shmuel
authors.initials: S
authors.lastname: Shtrasburg
authors.forename: Merav
authors.initials: M
authors.lastname: Lidar
authors.forename: Mordechai
authors.initials: M
authors.lastname: Pras
authors.forename: Clara
authors.initials: C
authors.lastname: Pariente
authors.forename: Rivka
authors.initials: R
authors.lastname: Gal
authors.forename: Avi
authors.initials: A
authors.lastname: Livneh
mesh_terms: D000305:Adrenal Cortex Hormones / Q000494:pharmacology*; D000686:Amyloidosis / Q000139:chemically induced / Q000188:drug therapy* / Q000276:immunology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D004195:Disease Models, Animal; D006023:Glycoproteins / Q000633:toxicity; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology; D051379:Mice; D012835:Silver Nitrate / Q000633:toxicity
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D006023:Glycoproteins; C046748:amyloid enhancing factor; D003907:Dexamethasone; D012835:Silver Nitrate; D006854:Hydrocortisone; D008775:Methylprednisolone